Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study
Titel:
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study
Auteur:
Kotsakis, A. Vetsika, E.-K. Christou, S. Hatzidaki, D. Vardakis, N. Aggouraki, D. Konsolakis, G. Georgoulias, V. Christophyllakis, Ch. Cordopatis, P. Kosmatopoulos, K. Mavroudis, D.